Skip to main content
Clinical Trials/EUCTR2005-005184-29-DE
EUCTR2005-005184-29-DE
Active, not recruiting
Not Applicable

Prevention of incipient carious lesions (white spot lesions) in patients with fixed orthodontic appliances following the application of elmex® gelée

GABA GmbH0 sites314 target enrollmentOctober 25, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
incipient carious lesions (white spot lesions)
Sponsor
GABA GmbH
Enrollment
314
Status
Active, not recruiting
Last Updated
12 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2006
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
GABA GmbH

Eligibility Criteria

Inclusion Criteria

  • \- Treatment plan: minimum of 10 teeth to be bonded labially
  • \- At least 10 years old
  • \- Highly effectively birth control for girls and women with child\-bearing potential (e. g. implants, oral contraceptives, injectables, plasters, sexual abstinence, vasectomised partner, IUDs)
  • \- Written declaration of informed consent
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • \- Known allergy to one of the components of the test products
  • \- Handicapped patients who have difficulties brushing their teeth
  • \- Pathological desquamation changes
  • \- Known Pregnancy
  • \- Breast feeding.
  • \- Eating disorders (e.g. bulimia, anorexia nervosa).
  • \- Disease that effects dental hard tissue (i.e. severe fluorosis, amelogenesis or dentinogenesis imperfecta)
  • \- Participation in another clinical trial either currently or within the last 30 days.

Outcomes

Primary Outcomes

Not specified

Similar Trials